10-Q
Quarterly Report
OAKTREE ACQUISITION CORP. III LIFE SCIENCES OACC OACCU OACCW
0001193125-25-178570
- Filed
- Aug 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$221.69K |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $1.39M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $1.36M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | −$6.54M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | −$6.52M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | −$6.07M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $1.12M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $727.32K |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $8.14M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $7.75M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $1.56M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $1.56M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $199.18M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $195.25M |
| Net Income | Q2 2025 · Jun 30, 2025 | $1.87M |
| Net Income | Q2 2025 · Jun 30, 2025 | $3.53M |
| Net Income | Q2 2025 · Mar 31, 2025 | $1.66M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$269.81K |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$714.61K |